Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria
Status:
Unknown status
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
Few efficient drugs for malaria treatment are available so far. Due to increased exposure of
these drugs and due to the high risk of development of drug resistant strains of Plasmodium
falciparum, new drug combinations have to be actively investigated. The investigators will
test the efficiency, safety and tolerance of combined fosmidomycin and clindamycin treatment
in acute uncomplicated malaria in children aged 3-10 years.
Phase:
Phase 2
Details
Lead Sponsor:
Zentopharm GmbH
Collaborators:
Albert Schweitzer Hospital Centro de Investigacao em Saude de Manhica